These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24351078)

  • 1. The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival.
    Smedbråten YV; Sagedal S; Leivestad T; Mjøen G; Osnes K; Rollag H; Reisaeter AV; Foss A; Os I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):120-6. PubMed ID: 24351078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival.
    Sagedal S; Hartmann A; Nordal KP; Osnes K; Leivestad T; Foss A; Degré M; Fauchald P; Rollag H
    Kidney Int; 2004 Jul; 66(1):329-37. PubMed ID: 15200441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.
    Werzowa J; Schwaiger B; Hecking M; Strassl R; Schmaldienst S; Böhmig GA; Genser B; Säemann MD
    Clin Transplant; 2015 Dec; 29(12):1230-8. PubMed ID: 26458731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
    Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
    Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.
    Erdbruegger U; Scheffner I; Mengel M; Schwarz A; Verhagen W; Haller H; Gwinner W
    Nephrol Dial Transplant; 2012 Jan; 27(1):435-43. PubMed ID: 21712490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
    Sund F; Tufveson G; Döhler B; Opelz G; Eriksson BM
    Nephrol Dial Transplant; 2013 Mar; 28(3):758-65. PubMed ID: 23243043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of donor kidney function and donor age on poor outcome of living-unrelated kidney transplantation (KT) in comparison with living-related KT.
    Park KS; Shin JH; Jang HR; Lee JE; Huh WS; Kim YG; Oh HY; Kim DJ
    Clin Transplant; 2014 Sep; 28(9):953-60. PubMed ID: 24861232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
    Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
    Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of risk-adapted antiviral prophylaxis and modern virus diagnosis for organ survival after kidney transplantation].
    Fricke L; Steinhoff J; Hartwig-Weber I; Bein G
    Dtsch Med Wochenschr; 1997 May; 122(18):565-71. PubMed ID: 9190308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?
    Kim JM; Kim SJ; Joh JW; Kwon CH; Song S; Shin M; Moon JI; Kim GS; Hong SH; Lee SK
    Liver Transpl; 2011 Apr; 17(4):446-55. PubMed ID: 21445928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
    von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
    J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy.
    Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
    Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
    Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
    Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
    Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients.
    Dahle DO; Jenssen T; Holdaas H; Leivestad T; Vårdal M; Mjøen G; Reisaeter AV; Toft I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):134-40. PubMed ID: 24372653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.